180 related articles for article (PubMed ID: 34739493)
1. Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers.
Gressel GM; Usyk M; Frimer M; Kuo DYS; Burk RD
PLoS One; 2021; 16(11):e0259188. PubMed ID: 34739493
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Kesterson J; Syriac S; Clark K; Frederick PJ; Lele S; Liu S
PLoS One; 2011 Mar; 6(3):e18066. PubMed ID: 21448288
[TBL] [Abstract][Full Text] [Related]
3. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
[TBL] [Abstract][Full Text] [Related]
4. IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.
Mhawech-Fauceglia P; Herrmann FR; Rai H; Tchabo N; Lele S; Izevbaye I; Odunsi K; Cheney RT
Am J Clin Pathol; 2010 Jun; 133(6):899-908. PubMed ID: 20472848
[TBL] [Abstract][Full Text] [Related]
5. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
6. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
Park JY; Nam JH; Kim YT; Kim YM; Kim JH; Kim DY; Sohn I; Lee SW; Sung CO; Kim KR
Virchows Arch; 2013 Mar; 462(3):289-96. PubMed ID: 23417747
[TBL] [Abstract][Full Text] [Related]
7. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma.
Al-Hussaini M; Stockman A; Foster H; McCluggage WG
Histopathology; 2004 Feb; 44(2):109-15. PubMed ID: 14764054
[TBL] [Abstract][Full Text] [Related]
8. Altered cervicovaginal microbiota in premenopausal ovarian cancer patients.
Morikawa A; Kawabata A; Shirahige K; Akiyama T; Okamoto A; Sutani T
Gene; 2022 Feb; 811():146083. PubMed ID: 34856363
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Kesterson J; Clark K; Monhollen L; Odunsi K; Lele S; Liu S
PLoS One; 2010 Nov; 5(11):e15415. PubMed ID: 21079744
[TBL] [Abstract][Full Text] [Related]
10. Endometrial microbiota from endometrial cancer and paired pericancer tissues in postmenopausal women: differences and clinical relevance.
Wang L; Yang J; Su H; Shi L; Chen B; Zhang S
Menopause; 2022 Oct; 29(10):1168-1175. PubMed ID: 36150116
[TBL] [Abstract][Full Text] [Related]
11. Vaginal and Cervical Microbiota Composition in Patients with Endometrial Cancer.
Barczyński B; Frąszczak K; Grywalska E; Kotarski J; Korona-Głowniak I
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175971
[TBL] [Abstract][Full Text] [Related]
12. Cervical cytology in serous and endometrioid endometrial cancer.
Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
[TBL] [Abstract][Full Text] [Related]
13. A 4-gene signature predicts prognosis of uterine serous carcinoma.
Chen H; Li L; Qin P; Xiong H; Chen R; Zhang M; Jiang Q
BMC Cancer; 2021 Feb; 21(1):154. PubMed ID: 33579221
[TBL] [Abstract][Full Text] [Related]
14. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
[TBL] [Abstract][Full Text] [Related]
15. Serous carcinoma arising in endometrial polyps: clinicopathologic study of 4 cases.
Idrees R; Din NU; Fatima S; Kayani N
Ann Diagn Pathol; 2013 Jun; 17(3):256-8. PubMed ID: 23276456
[TBL] [Abstract][Full Text] [Related]
16. Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M; Zolnik CP; Castle PE; Porras C; Herrero R; Gradissimo A; Gonzalez P; Safaeian M; Schiffman M; Burk RD;
PLoS Pathog; 2020 Mar; 16(3):e1008376. PubMed ID: 32214382
[TBL] [Abstract][Full Text] [Related]
17. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.
Nené NR; Reisel D; Leimbach A; Franchi D; Jones A; Evans I; Knapp S; Ryan A; Ghazali S; Timms JF; Paprotka T; Bjørge L; Zikan M; Cibula D; Colombo N; Widschwendter M
Lancet Oncol; 2019 Aug; 20(8):1171-1182. PubMed ID: 31300207
[TBL] [Abstract][Full Text] [Related]
18. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
19. The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status.
Vargas-Robles D; Romaguera J; Alvarado-Velez I; Tosado-Rodríguez E; Dominicci-Maura A; Sanchez M; Wiggin KJ; Martinez-Ferrer M; Gilbert JA; Forney LJ; Godoy-Vitorino F
mSystems; 2023 Aug; 8(4):e0035723. PubMed ID: 37534938
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Saccharomyces cerevisiae -like 1 (SEC14L1) in Gynecologic Malignancies Shows Overexpression in Endometrial Serous Carcinoma.
Banet N; Masnick M; Quddus MR
Int J Gynecol Pathol; 2023 Mar; 42(2):136-142. PubMed ID: 35283446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
